ReviewCancers2022
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges.
Hassan Awada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ReviewCancers2022
Hassan Awada et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.